When does stand-alone software qualify as a medical device in the European Union? The CJEU decision in SNITEM and what it implies for the next generation of medical devices
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
When does stand-alone software qualify as a medical device in the European Union? The CJEU decision in SNITEM and what it implies for the next generation of medical devices . / Minssen, Timo; Mimler, Marc; Mak, Vivian .
In: Medical Law Review, Vol. 28, No. 3, 01.07.2020, p. 615-624.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - When does stand-alone software qualify as a medical device in the European Union?
T2 - The CJEU decision in SNITEM and what it implies for the next generation of medical devices
AU - Minssen, Timo
AU - Mimler, Marc
AU - Mak, Vivian
PY - 2020/7/1
Y1 - 2020/7/1
N2 - This contribution analyses the first decision by the Court of Justice of the European Union (CJEU) on the qualification and regulation of stand-alone software as medical devices. Referring to the facts of the case and the applicable EU regulatory framework, the Court specifically found that prescription support software may constitute a medical device. This would even be the case where the software does not act directly in or on the human body. Yet, according to the CJEU it is necessary that the intended purpose falls within one or more of the 'medical purpose' categories of the regulatory definition of 'medical device'. The case has important implications, not only for specific legal debates. Together with the EU's new Medical Device Regulations and rapid technological progress it also signifies a paradigm shift with a rapidly increasing digitalization of the javascript:void(0);health and life sciences. This highlights the demand for continuous debates over the necessary evolution of the regulatory framework applying to the interface of medical AI and Big Data.
AB - This contribution analyses the first decision by the Court of Justice of the European Union (CJEU) on the qualification and regulation of stand-alone software as medical devices. Referring to the facts of the case and the applicable EU regulatory framework, the Court specifically found that prescription support software may constitute a medical device. This would even be the case where the software does not act directly in or on the human body. Yet, according to the CJEU it is necessary that the intended purpose falls within one or more of the 'medical purpose' categories of the regulatory definition of 'medical device'. The case has important implications, not only for specific legal debates. Together with the EU's new Medical Device Regulations and rapid technological progress it also signifies a paradigm shift with a rapidly increasing digitalization of the javascript:void(0);health and life sciences. This highlights the demand for continuous debates over the necessary evolution of the regulatory framework applying to the interface of medical AI and Big Data.
KW - Faculty of Law
KW - Software
KW - Medical Device Regulation
KW - Medical Device Directive
KW - Medical devices
KW - Healthcare
KW - E-health
KW - digital health
KW - Algorithms
KW - Apps
UR - https://academic.oup.com/medlaw/article-abstract/doi/10.1093/medlaw/fwaa012/5865470?redirectedFrom=fulltext
U2 - 10.1093/medlaw/fwaa012
DO - 10.1093/medlaw/fwaa012
M3 - Journal article
C2 - 32607541
VL - 28
SP - 615
EP - 624
JO - Medical Law Review
JF - Medical Law Review
SN - 0967-0742
IS - 3
ER -
ID: 231470441